Evaluating Biomarkers at Work in NSCLC

Evaluating Biomarkers at Work in NSCLC

Evaluating Biomarkers at Work in NSCLC
RestartResume

What are some of the challenges that come with using biomarkers to treat non-small cell lung cancer?

  • Overview

    What do we need to know about the role of biomarkers in non-small cell lung cancer? Dr. Mark Awad from the Dana-Farber Cancer Institute explains.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free